Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - GB SCIENCES INCex_242308.htm
EX-32.1 - EXHIBIT 32.1 - GB SCIENCES INCex_242307.htm
EX-31.2 - EXHIBIT 31.2 - GB SCIENCES INCex_242306.htm
EX-31.1 - EXHIBIT 31.1 - GB SCIENCES INCex_242305.htm
EX-21.1 - EXHIBIT 21.1 SUBSIDIARIES OF GB SCIENCES, INC. - GB SCIENCES INCex_242304.htm
EX-10.43 - EXHIBIT 10.43 - GB SCIENCES INCex_258922.htm
EX-10.42 - EXHIBIT 10.42 - GB SCIENCES INCex_258921.htm
EX-10.41 - EXHIBIT 10.41 - GB SCIENCES INCex_258920.htm
EX-10.40 - EXHIBIT 10.40 - GB SCIENCES INCex_258919.htm
EX-10.39 - EXHIBIT 10.39 - GB SCIENCES INCex_258918.htm
EX-10.38 - EXHIBIT 10.38 - GB SCIENCES INCex_258917.htm
EX-10.37 - EXHIBIT 10.37 - GB SCIENCES INCex_258916.htm
EX-10.36 - EXHIBIT 10.36 - GB SCIENCES INCex_258915.htm
EX-10.35 - EXHIBIT 10.35 - GB SCIENCES INCex_258914.htm
EX-10.34 - EXHIBIT 10.34 - GB SCIENCES INCex_258913.htm
EX-10.33 - EXHIBIT 10.33 - GB SCIENCES INCex_258912.htm
EX-10.32 - EXHIBIT 10.32 - GB SCIENCES INCex_258911.htm
EX-10.31 - EXHIBIT 10.31 - GB SCIENCES INCex_258910.htm
EX-10.30 - EXHIBIT 10.30 - GB SCIENCES INCex_258909.htm
EX-10.29 - EXHIBIT 10.29 - GB SCIENCES INCex_258908.htm
EX-10.28 - EXHIBIT 10.28 - GB SCIENCES INCex_258907.htm
10-K - FORM 10-K - GB SCIENCES INCgblx20210331_10k.htm

Exhibit 4.6

 

Common Stock

 

The holders of common stock are entitled to one vote per share on all matters to be voted on by stockholders and are entitled to receive such dividends, if any, as may be declared from time to time by our board of directors from funds legally available therefore, subject to the dividend preferences of the preferred stock, if any. Upon our liquidation or dissolution, the holders of common stock are entitled to share ratably in all assets available for distribution after payment of liabilities and liquidation preferences of the preferred stock, if any. Holders of common stock have no preemptive rights, no cumulative voting rights and no rights to convert their common stock into any other securities. Any action taken by holders of common stock must be taken at an annual or special meeting or by written consent of the holders of over 33% of our capital stock entitled to vote on such action.